Link to this page
National Cancer Institute Thesaurus
| Preferred Name | Sodium Phenylbutyrate | |
| Synonyms |
Sodium Phenylbutyrate Sodium 4-phenylbutyrate Sodium 4-Phenylbutyrate SODIUM PHENYLBUTYRATE phenylbutyrate 4-Phenylbutyric Acid, Sodium Salt Phenylbutyrate Sodium Buphenyl SPB11 |
|
| Definitions |
The sodium salt of phenylbutyrate, a derivative of the short-chain fatty acid butyrate, with potential antineoplastic activity. Phenylbutyrate reversibly inhibits class I and II histone deacetylases (HDACs), which may result in a global increase in gene expression, decreased cellular proliferation, increased cell differentiation, and the induction of apoptosis in susceptible tumor cell populations. |
|
| ID |
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C1440 |
|
| Accepted_Therapeutic_Use_For |
Adjunctive therapy for urea cycle disorders involving deficiencies of carbamoylphosphate synthetase; ornithine transcarbamylase; or argininosuccinic acid synthetase; S-S and S-C sickle cell disease; S-thalassemia hemoglobinopathy
|
|
| ALT_DEFINITION |
A substance that is being studied in the treatment of cancer. It belongs to the family of drugs called differentiating agents.
|
|
| CAS_Registry |
1716-12-7
|
|
| Chemical_Formula |
C10H11O2.Na
|
|
| code |
C1440
|
|
| Concept_In_Subset |
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C176424 http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C157711 http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C157712 http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C116978 http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C116977 http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C128784 |
|
| Contributing_Source |
CTRP FDA GDC
|
|
| DEFINITION |
The sodium salt of phenylbutyrate, a derivative of the short-chain fatty acid butyrate, with potential antineoplastic activity. Phenylbutyrate reversibly inhibits class I and II histone deacetylases (HDACs), which may result in a global increase in gene expression, decreased cellular proliferation, increased cell differentiation, and the induction of apoptosis in susceptible tumor cell populations.
|
|
| Display_Name |
Sodium Phenylbutyrate
|
|
| FDA_UNII_Code |
NT6K61736T
|
|
| FULL_SYN |
Sodium Phenylbutyrate Sodium 4-phenylbutyrate Sodium 4-Phenylbutyrate SODIUM PHENYLBUTYRATE phenylbutyrate 4-Phenylbutyric Acid, Sodium Salt Phenylbutyrate Sodium Buphenyl SPB11
|
|
| Has_Target | ||
| Is_Value_For_GDC_Property | ||
| label |
Sodium Phenylbutyrate
|
|
| Legacy Concept Name |
_4-Phenylbutyrate
|
|
| Maps_To |
Sodium Phenylbutyrate
|
|
| NCI_Drug_Dictionary_ID |
536018
|
|
| NSC Number |
657802
|
|
| PDQ_Closed_Trial_Search_ID |
536018
|
|
| PDQ_Open_Trial_Search_ID |
536018
|
|
| Preferred_Name |
Sodium Phenylbutyrate
|
|
| prefixIRI |
Thesaurus:C1440
|
|
| Semantic_Type |
Organic Chemical Pharmacologic Substance
|
|
| UMLS_CUI |
C0718066
|
|
| subClassOf |
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |